martin a_1e

The Zika Virus in Haiti

Dr. Louise Ivers

Many questions remain about Zika and its current impact on the Haitian population. Until more answers surface, BWH and Partners In Health(PIH) staff strive to find the best solutions for women, men, and children who may be adversely affected by the virus.

Louise Ivers, MD, MPH, of the BWH Division of Global Health Equity and senior health and policy advisor for PIH, answers questions about the mosquito’s resiliency, efforts to control it in Haiti and how PIH is working to prevent Zika infections and treat those who might be suffering from complications.

Read the Q&A on the PIH blog.

martin a_1e

Slowing the Spread of Cholera

The Crisis in Haiti
Louise Ivers leading earthquake relief efforts in Haiti in 2010; at right, caring for a young patient at a clinic in Haiti.

Louise C. Ivers, MD, MPH, and colleagues published a paper that shows exactly how much the vaccine Shanchol slowed the spread of cholera in villages north of St. Marc, Haiti, in 2012.

Writing in The Lancet Global Health online, Ivers, the senior health and policy adviser at Partners In Health, finds that Shanchol was widely effective when administered to thousands of adults and children in the region. “We found that there were about 65 percent fewer cholera cases among people that were vaccinated than there were in those

that were unvaccinated,” says Ivers, who is a member of BWH’s Division of Global Health Equity in the Department of Medicine.

It’s fantastic news, and not just for the obvious reason that fewer cholera cases means fewer cholera fatalities. Read the original story on the Partners In Health website.